Tuesday, Dec. 29, 2020 : Issue #1093 |
|
The Best of 2020, Part 2
In this special year-end issue, we count down our most popular articles from the second half of 2020 -- plus the three most popular articles for all of 2020. |
|
Letter from the Editor
Happy New Year from the staff and management of Diabetes in Control.
Last Saturday I was listening to my good friend and colleague, Joe Graedon, on the NPR show the People’s Pharmacy. Joe has hosted the show for about 1/2 a year longer than we have had Diabetes in Control. He brings a lot of interesting medical professionals and researchers to the show, and it is very informative both for the general public and medical professionals.
The topic was Vitamin D and COVID-19. The bottom line of the hour-long show was the positive value of Vitamin D supplementation to reduce risk of complications of the coronavirus.
This reminded me that one of our top 3 articles for 2020 was the value of Vitamin D in reducing the risk of diabetes (Laterpay). When you add the compounding risk of having diabetes and contracting COVID-19, you can see why this would be an article worth reading.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief |
|
| |
|
|
|
| Innovative Artificial Intelligence (AI) Tool Optimizes Care for T2D Patients
A new clinical software using artificial intelligence is being used for those with type 2 diabetes in Kentucky. It shows promising results in improving the Quality of Life for its residents and lowering treatment costs. This feature is the first in a 3-part series.
In Part 1: Adherence-related issues are hemorrhaging the costs of diabetes-related treatment in America. To offset this tragedy, GlucosePATH is utilized by a team of healthcare professionals dedicated to improving the quality of life while decreasing avoidable costs. |
| |
|
|
